Bellevue HEALTHCARE TRUST plc
LEI: 213800HQ3J3H9YF2UI82
6 September 2023
Director dealings
Bellevue Healthcare Trust plc announces that the undermentioned directors of the Company sold and following settlement, repurchased Ordinary Shares through a Bed and ISA arrangement, in order to affect the transfer of the Ordinary Shares to their respective ISA accounts.
The transactions are summarised below:
| Director | Shares sold | Shares acquired | Total holding following notification |
| Jo Dixon | 54,563 | 54,563 | 113,020 |
| Kate Bolsover | 6,223 | 6,184 | 23,056 |
| Paul Southgate | 6,223 | 6,223 | 91,947 |
Enquiries:
| Apex Listed Companies Services (UK) Limited | +44 20 3327 9720 |
| Company Secretary | |
| | |
The relevant notifications set out below are provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
| 1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
| a)
| Name
| Josephine Dixon | ||||
| 2
| Reason for the notification
| |||||
| a)
| Position/status
| Director | ||||
| b)
| Initial notification /Amendment
| Initial notification | ||||
| 3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
| a)
| Name
| Bellevue Healthcare Trust Plc | ||||
| b)
| LEI
|
213800HQ3J3H9YF2UI82 | ||||
| 4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
| a)
| Description of the financial instrument, type of instrument | Redeemable Ordinary Shares | ||||
| | | |||||
| Identification code |
| |||||
| | | |||||
| b)
| Nature of the transaction
| Sale of 54,563 shares and repurchase of 54,563 shares | ||||
| c)
| Price(s) and volume(s) |
| | | | |
| | | Price(s) | Volume(s) | | ||
| Transaction 1 (sale)
Transaction 2 (sale)
Transaction 3 (purchase)
| | 146.025p per share 146.40p per share
146.20p per share | 43,829 10,734
54,563 | | ||
| | | | | | ||
| d)
| Aggregated information | | ||||
| | | |||||
| - Aggregated volume
| Sale: 54,563 | |||||
| | | |||||
| - Price | Total price sale: £79,715.30 | |||||
| | | |||||
| e)
| Date of the transaction
| 5 September 2023 | ||||
| f)
| Place of the transaction
| London Stock Exchange | ||||
| 1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
| a)
| Name
| Paul Southgate | ||||
| 2
| Reason for the notification
| |||||
| a)
| Position/status
| Director | ||||
| b)
| Initial notification /Amendment
| Initial notification | ||||
| 3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
| a)
| Name
| Bellevue Healthcare Trust Plc | ||||
| b)
| LEI
|
213800HQ3J3H9YF2UI82 | ||||
| 4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
| a)
| Description of the financial instrument, type of instrument | Redeemable Ordinary Shares | ||||
| | | |||||
| Identification code |
| |||||
| | | |||||
| b)
| Nature of the transaction
| Sale of 6,223 shares and repurchase of 6,223 shares | ||||
| c)
| Price(s) and volume(s)
| | | | | |
| | | Price(s) | Volume(s) | | ||
| Transaction 1 (sale)
Transaction 2 (purchase)
| | 146.862p per share
147.0321p per share | 6,223
6,223 | | ||
| | | | | | ||
| d)
| Aggregated information | | ||||
| | | |||||
| - Aggregated volume | Sale: 6,223 | |||||
| | | |||||
| - Price | Total price sale: £9,127.27 | |||||
| | | |||||
| e)
| Date of the transaction
| 4 September 2023 | ||||
| f)
| Place of the transaction
| London Stock Exchange | ||||
| 1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
| a)
| Name
| Kate Bolsover | ||||
| 2
| Reason for the notification
| |||||
| a)
| Position/status
| Director | ||||
| b)
| Initial notification /Amendment
| Initial notification | ||||
| 3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
| a)
| Name
| Bellevue Healthcare Trust Plc | ||||
| b)
| LEI
|
213800HQ3J3H9YF2UI82 | ||||
| 4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
| a)
| Description of the financial instrument, type of instrument | Redeemable Ordinary Shares | ||||
| | | |||||
| Identification code |
| |||||
| | | |||||
| b)
| Nature of the transaction
| Sale of 6,223Ordinary Shares and repurchase of 6,184 Ordinary Shares | ||||
| c)
| Price(s) and volume(s) | | | | | |
| | | Price(s) | Volume(s) | | ||
| Transaction 1 (sale) | | 148.80p per share | 6,223 | | ||
| Transaction 2 (purchase) | | 148.80p per share | 6,184 | | ||
|
| | | | | ||
| d)
| Aggregated information | | ||||
| | | |||||
| - Aggregated volume | Sale: 6,223 shares Purchase: 6,184 shares
| |||||
| - Price | Total sale price: £9,259.82 Total Purchase Price: £9,201.79 | |||||
| | | |||||
| e)
| Date of the transaction
| 4 September 2023 | ||||
| f)
| Place of the transaction
| London Stock Exchange | ||||
END
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
